Point72 Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Point72 Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-185	Closed	-$7.28K	–	3009
2023 Q2	$7.28K	Buy	+185	New	+$6.53K	﹤0.01%	1943
2023 Q1	–	Sell	-2,967,729	Closed	-$63.5M	–	2614
2022 Q4	$63.5M	Buy	2,967,729 +2,360,829	+389%	+$50.4M	0.22%	117
2022 Q3	$10.9M	Buy	+606,900	New	+$7.97M	0.04%	484
2017 Q3	–	Sell	-150,000	Closed	-$384K	–	1105
2017 Q2	$384K	Buy	+150,000	New	+$409K	﹤0.01%	779
2016 Q4	–	Sell	-786,300	Closed	-$36.3M	–	871
2016 Q3	$36.3M	Buy	+786,300	New	+$44.3M	0.26%	107
2016 Q2	–	Sell	-414,400	Closed	-$17.5M	–	912
2016 Q1	$17.5M	Buy	+414,400	New	+$21.1M	0.13%	187

Point72 Asset Management's ISEE Position: Q3 2023 in Review

Point72 Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 185 shares — an estimated $7.28K sold.

Point72 Asset Management first reported a position in ISEE in Q1 2016 and held it in 6 quarters. The position peaked at $63.5M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Point72 Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Point72 Asset Management sold 185 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $7.28K.
Point72 Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 6 quarters.
Point72 Asset Management's IVERIC bio, Inc. Common Stock position peaked at $63.5M in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.